Barry E. Greene
2018 - Alnylam Pharmaceuticals
In 2018, Barry E. Greene earned a total compensation of $3M as Former President at Alnylam Pharmaceuticals, a 217% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $232,000 |
|---|---|
| Option Awards | $2,161,275 |
| Salary | $580,000 |
| Other | $21,108 |
| Total | $2,994,383 |
Greene received $2.2M in option awards, accounting for 72% of the total pay in 2018.
Greene also received $232K in non-equity incentive plan, $580K in salary and $21.1K in other compensation.
Rankings
In 2018, Barry E. Greene's compensation ranked 3,872nd out of 14,244 executives tracked by ExecPay. In other words, Greene earned more than 72.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,872 out of 14,244 | 73rd |
Division Manufacturing | 1,429 out of 5,759 | 75th |
Major group Chemicals And Allied Products | 507 out of 2,122 | 76th |
Industry group Drugs | 424 out of 1,811 | 77th |
Industry Pharmaceutical Preparations | 330 out of 1,385 | 76th |
Source: SEC filing on April 2, 2021.
Greene's colleagues
We found four more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2018.